Skip to main
PAYS
PAYS logo

PaySign Inc (PAYS) Stock Forecast & Price Target

PaySign Inc (PAYS) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PaySign Inc. is projected to experience a robust revenue growth of 26% year-over-year in 2025, reaching a total of $73.4 million, alongside a significant increase in adjusted EBITDA, which is expected to rise by 72% year-over-year to $16.6 million. Additionally, the company anticipates an expansion of adjusted EBITDA margins, forecasted to grow by 570 to 650 basis points year-over-year, reaching between 22.2% and 23.0%, primarily driven by higher margins in its pharmaceutical segment. Furthermore, in the first quarter, PaySign reported an impressive 193% year-over-year increase in adjusted EBITDA to $5.0 million, surpassing forecasts by $0.6 million, indicating strong operational performance.

Bears say

PaySign Inc. experienced a significant contraction in its Plasma Donor Compensation segment, with revenue declining by 9% year-over-year to $9.4 million, falling short of forecasts by 5%. This decline is attributed to an oversupply of plasma in the U.S., driven by new extraction techniques that have reduced the average donor compensation per unit. Furthermore, historical performance reflects a concerning trend, as total revenue in 2020 plummeted by 30% year-over-year to $24 million, alongside a negative adjusted EBITDA of $2.8 million, down from a positive $10.1 million in 2019.

PaySign Inc (PAYS) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PaySign Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PaySign Inc (PAYS) Forecast

Analysts have given PaySign Inc (PAYS) a Strong Buy based on their latest research and market trends.

According to 4 analysts, PaySign Inc (PAYS) has a Strong Buy consensus rating as of Oct 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PaySign Inc (PAYS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.